Weight Loss Clinic in Aylestone
Mounjaro and Wegovy, prescribed by a GPhC-registered Independent Prescriber and dispensed on-site. A mile and a half from Aylestone, free initial consultation.
Real weight loss, prescribed properly — a mile and a half from Aylestone.
Aylestone residents don't need to wait months for an NHS weight management referral to access GLP-1 medication. Clarendon Pharmacy on Welford Road runs a pharmacist-led weight loss clinic just a mile and a half from Aylestone — around six minutes by car straight up Aylestone Road which becomes Welford Road, with free patient parking on-site.
Mounjaro (tirzepatide) and Wegovy (semaglutide) are prescription-only medicines that need a qualified prescriber. The clinic is led by Mohammed Kolia (MPharm, IP), a GPhC-registered Independent Prescriber, which means we can assess, prescribe, dispense and review your treatment all in one place. No relay through a GP, no separate online prescriber sitting in another city.
Treatment starts with a free, no-obligation consultation. We'll check your BMI, run through your medical history, your goals, and confirm whether GLP-1 treatment is clinically appropriate. NICE recommends these medicines for adults with a BMI of 30 or above (or 27.5 if you have a weight-related condition like type 2 diabetes, hypertension, or sleep apnoea).
After your first prescription you'll book back monthly for a check-in — weight, side effects, dose escalation if appropriate, and your next month's supply. Most patients see clear progress within 12–16 weeks. No subscription, no contract — you stop when you're ready.
GLP-1 weight loss treatment for Aylestone residents
Aylestone is a direct mile and a half from Clarendon Pharmacy — straight up Aylestone Road which becomes Welford Road. About six minutes by car. For Aylestone residents considering Mounjaro or Wegovy, the proximity makes monthly review appointments low-friction — you don't lose a day to travel.
NHS Tier 3 weight-management services covering Aylestone have 12–24 month waiting lists with strict eligibility thresholds (typically BMI 35+, or 32.5+ with comorbidity). For adults who meet NICE eligibility (BMI 30+, or 27.5+ with a weight-related condition like type 2 diabetes, hypertension or sleep apnoea) but want to start within weeks rather than years, private is the practical route.
How do Mounjaro and Wegovy work?
Both mimic GLP-1, a hormone naturally released after eating that signals fullness and slows stomach emptying. Mounjaro additionally acts on GIP (glucose-dependent insulinotropic polypeptide), making it a dual GLP-1/GIP agonist. In practice:
- You feel full sooner, on smaller meals.
- You feel hungry less often between meals.
- Food cravings reduce significantly for most people.
- Stomach emptying slows, prolonging satiety.
NHS Tier 3 vs private — the honest comparison
NHS Tier 3 weight-management services are excellent when you can access them, and free. They include dietitian support, group education, and — in some cases — access to GLP-1 prescribing. The catch: waiting lists run 12–24 months, with strict BMI thresholds (typically 35+, or 32.5+ with comorbidity). For Aylestone residents whose BMI is in the 27.5–34.9 range, or who can't wait years, private is the only realistic option.
We're not in competition with the NHS — we're a complementary access point for people the NHS pathway doesn't currently reach quickly. If you fit Tier 3 criteria and can wait, ask your GP about referral first.
Mounjaro vs Wegovy
In head-to-head trials, Mounjaro tends to produce greater average weight loss:
- Mounjaro (15mg weekly) — SURMOUNT-1 trial: average 21% body-weight reduction over 72 weeks.
- Wegovy (2.4mg weekly) — STEP-1 trial: average 15% body-weight reduction over 68 weeks.
Individual response varies. Some respond better to Wegovy than Mounjaro. As an Independent Prescriber, Mohammed Kolia can switch you between products if one isn't working.
NICE eligibility
| BMI | Eligibility |
|---|---|
| 30 or above | Eligible (general population) |
| 27.5–29.9 | Eligible IF weight-related condition present |
| Below 27.5 | Not recommended |
What to expect
Weeks 1–4: modest appetite reduction, possible nausea first few days after each injection, weight loss 1–3kg. Weeks 5–8: appetite reduction more pronounced, side effects settling, weight loss accelerates. Months 3–6: dose escalates to maintenance, 5–12% body weight loss typical. Months 6–12: 15–20% total weight loss common; metabolic markers improve.
Side effects worth knowing
Most common: nausea, indigestion, constipation or diarrhoea, weeks 1–8. Less common: gallbladder problems (rapid weight loss raises gallstone risk); pancreatitis (rare, severe abdominal pain is a red flag); thyroid effects (contraindicated in personal/family history of medullary thyroid cancer or MEN-2). Full prescribing information at the eMC Summary of Product Characteristics for Mounjaro KwikPen.
Lifestyle alongside treatment
GLP-1 medications work best alongside lifestyle changes: strength training 2–3x weekly preserves muscle mass during weight loss; 0.8–1.2g protein per kg target weight daily aids satiety; 7,500–10,000 daily steps achievable on appetite-suppressed days; sleeping less than 7 hours raises appetite-stimulating ghrelin.
Stopping treatment
Weight regain is the honest concern — trials show patients regain ~two-thirds of lost weight within a year of stopping unless lasting behavioural changes are embedded. The strategy that works: use GLP-1 treatment as a window to embed habits that survive without it (strength training, protein-forward eating, structured eating windows, resolved sleep debt). Then taper rather than stopping abruptly, with continuing review.
How much does it cost?
Pricing varies by dose. We charge for medication only — the initial consultation, monthly reviews, injection demonstration, and prescription itself are all included. Full monthly figure given at consultation. No subscription, no auto-billing.
Getting to Welford Road from Aylestone
Straight up Aylestone Road which becomes Welford Road. 1.5 miles, about six minutes by car. Free patient parking on-site. The 19, 84, and 85 buses run regularly. Cyclists have a dedicated cycle lane on much of Aylestone Road / Welford Road. For monthly reviews, this proximity matters — it's a 30-minute total time commitment including drive and 15-minute review.
What's included in your weight loss programme.
Free initial consultation, GLP-1 prescription on-site by an Independent Prescriber, monthly progress reviews. No subscription, no contract.
Free initial consultation
Mounjaro (tirzepatide)
Wegovy (semaglutide)
Independent Prescriber on-site
Monthly progress reviews
Stop anytime
Three steps from consultation to first injection.
Free consultation, prescription, monthly reviews. Stop anytime.
Free initial consultation
Prescription and first injection
Monthly reviews and dose escalation
A mile and a half from Aylestone. Free patient parking.
Walk-in welcome Monday to Saturday. Same-day bookings available most of the time.
North on Aylestone Road which becomes Welford Road. 6 minutes by car.
- Mon09:00 – 19:00
- Tue09:00 – 19:00
- Wed09:00 – 19:00
- Thu09:00 – 19:00
- Fri09:00 – 19:00
- Sat09:00 – 17:00
- SunClosed
Common questions about Mounjaro and Wegovy.
If your question isn't here, give us a call and we'll talk it through.
References for this page
Every clinical claim above is sourced from an authoritative public reference.
- 01NICE TA1026NICETirzepatide for managing overweight and obesityhttps://www.nice.org.uk/guidance/ta1026Accessed 12 May 2026
- 02NICE TA875NICESemaglutide for managing overweight and obesityhttps://www.nice.org.uk/guidance/ta875Accessed 12 May 2026
- 03MHRA Drug Safety UpdateMHRAGLP-1 receptor agonists — prescribing and safety informationhttps://www.gov.uk/drug-safety-updateAccessed 12 May 2026
- 04Electronic Medicines Compendium (eMC)MHRAMounjaro KwikPen Summary of Product Characteristicshttps://www.medicines.org.uk/emc/product/14149Accessed 12 May 2026
- 05NHSNHSObesity overview and treatment optionshttps://www.nhs.uk/conditions/obesity/Accessed 12 May 2026
- 06General Pharmaceutical CouncilGPHCRegister entry — Mohammed Kolia (Reg. 2073260)https://www.pharmacyregulation.org/registers/pharmacist/2073260Accessed 12 May 2026
Information on this page is for general guidance. Suitability for GLP-1 weight loss treatment depends on BMI, medical history, and clinical assessment. A consultation determines whether treatment is appropriate.
